SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-000168
Filing Date
2023-01-03
Accepted
2023-01-03 16:06:00
Documents
13
Period of Report
2023-01-03
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K arav20230103_8k.htm   iXBRL 8-K 49937
  Complete submission text file 0001437749-23-000168.txt   188887

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA arav-20230103.xsd EX-101.SCH 3600
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arav-20230103_def.xml EX-101.DEF 11531
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE arav-20230103_lab.xml EX-101.LAB 15413
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arav-20230103_pre.xml EX-101.PRE 11687
7 EXTRACTED XBRL INSTANCE DOCUMENT arav20230103_8k_htm.xml XML 2550
Mailing Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098
Business Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 936-355-1910
Aravive, Inc. (Filer) CIK: 0001513818 (see all company filings)

IRS No.: 264106690 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36361 | Film No.: 23502100
SIC: 2834 Pharmaceutical Preparations